Archives of Pharmacal Research

Papers
(The median citation count of Archives of Pharmacal Research is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Mouse models of nonalcoholic steatohepatitis and their application to new drug development188
CD48-expressing non-small-cell lung cancer cells are susceptible to natural killer cell–mediated cytotoxicity144
Evaluation of bone health and fracture risk in type 2 diabetes: a network meta-analysis of anti-diabetic treatments versus placebo73
Renal tubular PAR2 promotes interstitial fibrosis by increasing inflammatory responses and EMT process72
Continuous TNF-α exposure in mammary epithelial cells promotes cancer phenotype acquisition via EGFR/TNFR2 activation71
Osteogenic effect of an adiponectin-derived short peptide that rebalances bone remodeling: a potential disease-modifying approach for postmenopausal osteoporosis therapy58
Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities52
Correction to: The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer51
Challenges and opportunities of developing small-molecule therapies for age-related macular degeneration49
Impact of binge drinking on alcoholic liver disease47
Retraction Note: Anti-inflammatory effect of atorvastatin on vascular reactivity and insulin resistance in fructose fed rats46
Myriocin suppresses tumor growth by modulating macrophage polarization and function through the PI3K/Akt/mTOR pathway45
Anti-fibrotic effect of aurocyanide, the active metabolite of auranofin40
Regulation of NOX/p38 MAPK/PPARα pathways and miR-155 expression by boswellic acids reduces hepatic injury in experimentally-induced alcoholic liver disease mouse model: novel mechanistic insight39
Prenylated flavonoid fractions from Glycyrrhiza glabra alleviate insulin resistance in HepG2 cells by regulating the ERK/IRS-1 and PI3K/Akt signaling pathways38
Advances in plant-derived natural products for antitumor immunotherapy36
Donepezil improves skeletal muscle insulin resistance in obese mice via the AMPK/FGF21-mediated suppression of inflammation and ferroptosis35
Antibody-drug conjugates in cancer therapy: innovations, challenges, and future directions35
The role and application of transcriptional repressors in cancer treatment34
Minor structural changes, major functional impacts: posttranslational modifications and drug targets33
Isolation, structure elucidation, total synthesis, and biosynthesis of dermazolium A, an antibacterial imidazolium metabolite of a vaginal bacterium Dermabacter vaginalis31
Non-alcoholic fatty liver disease and liver secretome31
Recent advances on Pestalotiopsis genus: chemistry, biological activities, structure–activity relationship, and biosynthesis31
A review on bacteria-derived antioxidant metabolites: their production, purification, characterization, potential applications, and limitations30
Naringin promotes fat browning mediated by UCP1 activation via the AMPK signaling pathway in 3T3-L1 adipocytes30
Effects of fluconazole on the pharmacokinetics of celecoxib and its carboxylic acid metabolite in different CYP2C9 genotypes30
Ginsenoside Rh1 inhibits tumor growth in MDA-MB-231 breast cancer cells via mitochondrial ROS and ER stress-mediated signaling pathway28
Anti-angiogenesis revisited: reshaping the treatment landscape of advanced non-small cell lung cancer28
Tumor microenvironment regulation by reactive oxygen species-mediated inflammasome activation28
Triterpenoids from Dysoxylum genus and their biological activities25
Anti-osteoporosis effects of triterpenoids from the fruit of sea buckthorn (Hippophae rhamnoides) through the promotion of osteoblast differentiation in mesenchymal stem cells, C3H10T1/224
Cell membrane chromatography relative competitive method for the accurate determination of relative KD values of drug-receptor interactions24
Phytochemistry and pharmacology of plants in the genus Chaenomeles22
Immunosenescence and age-related immune cells: causes of age-related diseases21
The inhibition of endothelial DLL4-NOTCH1 signaling by 2'-hydroxyflavanone enhances anti-PD-1 therapy in melanoma21
Predictive biomarkers for molecularly targeted therapies and immunotherapies in breast cancer21
Pralsetinib: chemical and therapeutic development with FDA authorization for the management of RET fusion-positive non-small-cell lung cancers21
Discovery and synthesis of 1,2,4-oxadiazole derivatives as novel inhibitors of Zika, dengue, Japanese encephalitis, and classical swine fever virus infections21
The effects of BRL-50481 on ovalbumin-induced asthmatic lung inflammation exacerbated by co-exposure to Asian sand dust in the murine model21
Dapagliflozin attenuates myocardial remodeling in hypertension by activating the circadian rhythm signaling pathway20
Immune-related pathogenesis and therapeutic strategies of nonalcoholic steatohepatitis19
Potential of natural products in inflammation: biological activities, structure–activity relationships, and mechanistic targets19
Cathepsin B maturation plays a critical role in leptin-induced hepatic cancer cell growth through activation of NLRP3 inflammasomes19
Antibacterial properties of natural products from marine fungi reported between 2012 and 2023: a review19
Potential effects of a human milk oligosaccharide 6′-sialyllactose on angiotensin II-induced aortic aneurysm via p90RSK/TGF-β/SMAD2 signaling pathway19
Effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of gliclazide in healthy subjects19
Biomedical features and therapeutic potential of rosmarinic acid19
Effects of CYP2C9*3 and *13 alleles on the pharmacokinetics and pharmacodynamics of glipizide in healthy Korean subjects19
Correction to: Site-selective and metal-free C–H nitration of biologically relevant N-heterocycles19
Paeonia genus: a systematic review of active ingredients, pharmacological effects and mechanisms, and clinical applications for the treatment of cancer18
Selumetinib overcomes gefitinib primary and acquired resistance by regulating MIG6/STAT3 in NSCLC18
Effects of CYP2D6 and CYP2C19 genetic polymorphisms and cigarette smoking on the pharmacokinetics of tolperisone18
New tricyclic systems as photosensitizers towards triple negative breast cancer cells18
Akt-activated GSK3β inhibitory peptide effectively blocks tau hyperphosphorylation18
Cardiotoxicity linked to anticancer agents and cardioprotective strategy17
Mechanistic insights and emerging therapeutic strategies targeting endothelial dysfunction in cardiovascular diseases17
Biodegradable gelatin methacryloyl microneedles: a new paradigm in transdermal drug delivery17
New phenalenone derivatives from the Hawaiian volcanic soil-associated fungus Penicillium herquei FT729 and their inhibitory effects on indoleamine 2,3-dioxygenase 1 (IDO1)17
Curcumin targets CXCL16-mediated podocyte injury and lipid accumulation in diabetic kidney disease treatment16
Inhibition of autophagy with chloroquine dysregulates mitochondrial quality control and energetics in adipocytes16
Scope and challenges of nanoparticle-based mRNA delivery in cancer treatment16
Advanced therapeutic strategies targeting microglia: beyond neuroinflammation16
Advances in sarcopenia: mechanisms, therapeutic targets, and intervention strategies16
Activation of cryptic biosynthetic pathways in Saccharopolyspora spinosa through deletion of the spinosyn gene cluster: induction of cryptic and bioactive natural products16
Physiologically based pharmacokinetic (PBPK) modeling of pitavastatin in relation to SLCO1B1 genetic polymorphism15
Physiologically based pharmacokinetic (PBPK) modeling of piroxicam with regard to CYP2C9 genetic polymorphism15
Effects of CYP2D6*10 allele on the pharmacokinetics of tolperisone14
Human milk oligosaccharides 3′-sialyllactose and 6′-sialyllactose attenuate LPS-induced lung injury by inhibiting STAT1 and NF-κB signaling pathways14
Dual roles of myeloid-derived suppressor cells in various diseases: a review14
Physiologically based pharmacokinetic modelling to predict the pharmacokinetics of metoprolol in different CYP2D6 genotypes14
PET tracer development for imaging α-synucleinopathies14
Paeoniflorin increases the survival of Pseudomonas aeruginosa infected Caenorhabditis elegans at the immunosuppression stage by activating PMK-1, BAR-1, and EGL-1 signals13
Sanguinarine impairs lysosomal function and induces ROS-dependent mitophagy and apoptosis in human hepatocellular carcinoma cells13
Biological insights and therapeutic potential of Glycyrrhiza uralensis and its bioactive compounds: an updated review13
Insights into biological activities profile of gingerols and shogaols for potential pharmacological applications13
Recent advances in selective and targeted drug/gene delivery systems using cell-penetrating peptides12
E3 ubiquitin ligase RNF180 mediates the ALKBH5/SMARCA5 axis to promote colon inflammation and Th17/Treg imbalance in ulcerative colitis mice12
Death-associated protein kinase 1 phosphorylates MDM2 and inhibits its protein stability and function11
Indole-3-acetic acid ameliorates dextran sulfate sodium-induced colitis via the ERK signaling pathway11
Curcumin monoglucuronide protects cartilage from progressive degeneration by blocking MMP-1311
Physiologically based pharmacokinetic (PBPK) modeling of gliclazide for different genotypes of CYP2C9 and CYP2C1911
Effects of CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy subjects11
Physiologically based pharmacokinetic modeling of candesartan related to CYP2C9 genetic polymorphism in adult and pediatric patients11
Role of mitochondrial dynamics and mitophagy of vascular smooth muscle cell proliferation and migration in progression of atherosclerosis10
Comparative evaluation of bioactive phytochemicals in Spinacia oleracea cultivated under greenhouse and open field conditions10
Latest research progress on anticancer effect of baicalin and its aglycone baicalein10
Modulating versatile pathways using a cleavable PEG shell and EGFR-targeted nanoparticles to deliver CRISPR-Cas9 and docetaxel for triple-negative breast cancer inhibition10
Diacerein counteracts acetaminophen-induced hepatotoxicity in mice via targeting NLRP3/caspase-1/IL-1β and IL-4/MCP-1 signaling pathways10
Role of monocarboxylate transporter I/lactate dehydrogenase B-mediated lactate recycling in tamoxifen-resistant breast cancer cells10
Exploring NNMT: from metabolic pathways to therapeutic targets10
Protection of the hematopoietic system against radiation-induced damage: drugs, mechanisms, and developments10
Enhancer regulation in cancer: from epigenetics to m6A RNA modification10
Ionically bridged dexamethasone sodium phosphate–zinc–PLGA nanocomplex in alginate microgel for the local treatment of ulcerative colitis10
Oleanolic acid activates the JNK-Sp1-DJ-1 axis to promote mitophagy-mediated neuroprotection in dopaminergic neurons for Parkinson’s disease treatment9
mRNA vaccines: the most recent clinical applications of synthetic mRNA9
Multifaceted roles of mitochondrial dysfunction in diseases: from powerhouses to saboteurs9
Low-dose curcumin enhances hippocampal neurogenesis and memory retention in young mice9
New autophagy-modulating lanostane-type triterpenoids from a hallucinogenic poisonous mushroom Gymnopilus orientispectabilis9
Apocynin abrogates methotrexate-induced nephrotoxicity: role of TLR4/NF-κB-p65/p38-MAPK, IL-6/STAT-3, PPAR-γ, and SIRT1/FOXO3 signaling pathways9
Antitumor activity of Polygonatum sibiricum polysaccharides9
Innate immune sensing of pathogens and its post-transcriptional regulations by RNA-binding proteins9
Prediction of human pharmacokinetic parameters incorporating SMILES information8
Neurological disorders of COVID-19: insights to applications of natural products from plants and microorganisms8
Targeting dysregulated lipid metabolism in the tumor microenvironment8
Herbal medicine and gut microbiota: exploring untapped therapeutic potential in neurodegenerative disease management8
C-phycocyanin reinforces autophagy to block pulmonary fibrogenesis by inhibiting lncIAPF biogenesis8
Silybin inhibits succinate production and secretion in hepatocytes to reverse liver fibrosis8
Retraction Note: MiR-338-5p ameliorates pathological cardiac hypertrophy by targeting CAMKIIδ8
Physiologically based pharmacokinetic (PBPK) modeling of flurbiprofen in different CYP2C9 genotypes8
Metformin mitigates renal dysfunction in obese insulin-resistant rats via activation of the AMPK/PPARα pathway8
0.21100902557373